Cigarette smoke enhances chemotaxis via acetylation of proline-glycine- proline

Frontiers in Bioscience - Elite

Volumn 4 E, Issue 7, 2012, Pages 2402-2409

  Hardison, Matthew Thomas ^a   Brown, Michael David ^a   Snelgrove, Robert James ^b   Blalock, James Edwin ^a   Jackson, Patricia ^a  

^a University of Alabama at Birmingham   (United States)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Acetaldehyde; Acetylation; Acrolein; Cigarette Smoke; Neutrophils; PGP

Indexed keywords

ACETALDEHYDE; ACETYLCYSTEINE; ACROLEIN; BIOLOGICAL MARKER; CARBOCISTEINE; CIGARETTE SMOKE; CIGARETTE SMOKE CONDENSATE; PROLYLGLYCYLPROLINE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; OLIGOPEPTIDE; PROLINE; PROLYL GLYCYL PROLINE; PROLYL-GLYCYL-PROLINE;

ACETYLATION; ARTICLE; CHEMOTAXIS; HUMAN; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; SMOKING; VAPOR; CYTOLOGY; METABOLISM; SMOKE; TOBACCO;

NICOTIANA TABACUM;

ACETYLATION; ACETYLCYSTEINE; CARBOCYSTEINE; CHEMOTAXIS, LEUKOCYTE; HUMANS; NEUTROPHILS; OLIGOPEPTIDES; PROLINE; SMOKE; TOBACCO;

EID: 84867314792     PISSN: 19450494     EISSN: 19450508     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. M. Hardison, Jackson, PL, Blalock, JE, Gaggar, A: Protease Release from Neutrophils in Inflammation: Impact on Innate Immunity Seen in Chronic Pulmonary Disease. In: Handbook of Granulocytes: Classification, Toxic Materials Produced and Pathology. Ed R. H. a. S. Kohlund. Nova Science Publishers, (2009))
2. P. J. Barnes: Chronic obstructive pulmonary disease. N Engl J Med, 343(4), 269-80 (2000)) (Pubitemid 30490396)
3. J. A. Belperio, S. S. Weigt, M. C. Fishbein and J. P. Lynch, 3rd: Chronic lung allograft rejection: mechanisms and therapy. Proc Am Thorac Soc, 6(1), 108-21 (2009))
4. M. T. Hardison, F. S. Galin, C. E. Calderon, U. V. Djekic, S. B. Parker, K. M. Wille, P. L. Jackson, R. A. Oster, K. R. Young, J. E. Blalock and A. Gaggar: The presence of a matrix-derived neutrophil chemoattractant in bronchiolitis obliterans syndrome after lung transplantation. J Immunol, 182(7), 4423-31 (2009))
5. A. Gaggar, Y. Li, N. Weathington, M. Winkler, M. Kong, P. Jackson, J. E. Blalock and J. P. Clancy: Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients. Am J Physiol Lung Cell Mol Physiol, 293(1), L96-L104 (2007)) (Pubitemid 47080717)
6. N. M. Weathington, A. H. van Houwelingen, B. D. Noerager, P. L. Jackson, A. D. Kraneveld, F. S. Galin, G. Folkerts, F. P. Nijkamp and J. E. Blalock: A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med, 12(3), 317-23 (2006)) (Pubitemid 43355080)
7. A. Gaggar, P. L. Jackson, B. D. Noerager, P. J. O'Reilly, D. B. McQuaid, S. M. Rowe, J. P. Clancy and J. E. Blalock: A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol, 180(8), 5662-9 (2008))
8. P. O'Reilly, P. L. Jackson, B. Noerager, S. Parker, M. Dransfield, A. Gaggar and J. E. Blalock: N-alpha-PGP and PGP, potential biomarkers and therapeutic targets for COPD. Respir Res, 10, 38 (2009))
9. R. J. Snelgrove, P. L. Jackson, M. T. Hardison, B. D. Noerager, A. Kinloch, A. Gaggar, S. Shastry, S. M. Rowe, Y. M. Shim, T. Hussell and J. E. Blalock: A critical role for LTA4H in limiting chronic pulmonary neutrophilic inflammation. Science, 330(6000), 90-4 (2010))
10. T. Mio, D. J. Romberger, A. B. Thompson, R. A. Robbins, A. Heires and S. I. Rennard: Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Crit Care Med, 155(5), 1770-6 (1997))
11. U. V. Djekic, A. Gaggar and N. M. Weathington: Attacking the multi-tiered proteolytic pathology of COPD: new insights from basic and translational studies. Pharmacol Ther, 121(2), 132-46 (2009))
12. E. Mortaz, G. Folkerts, F. P. Nijkamp and P. A. Henricks: ATP and the pathogenesis of COPD. Eur J Pharmacol, 638(1-3), 1-4 (2010))
13. J. Z. Dong and S. C. Moldoveanu: Gas chromatographymass spectrometry of carbonyl compounds in cigarette mainstream smoke after derivatization with 2,4-dinitrophenylhydrazine. J Chromatogr A, 1027(1-2), 25-35 (2004)) (Pubitemid 38077046)
14. P. N. Black, A. Morgan-Day, T. E. McMillan, P. J. Poole and R. P. Young: Randomised, controlled trial of Nacetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC Pulm Med, 4, 13 (2004))
15. J. P. Zheng, J. Kang, S. G. Huang, P. Chen, W. Z. Yao, L. Yang, C. X. Bai, C. Z. Wang, C. Wang, B. Y. Chen, Y. Shi, C. T. Liu, Q. Li, Z. S. Wang, Y. J. Huang, Z. Y. Luo, F. P. Chen, J. Z. Yuan, B. T. Yuan, H. P. Qian, R. C. Zhi and N. S. Zhong: Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study. Lancet, 371(9629), 2013-8 (2008))
16. I. M. Ahmad, B. E. Britigan and M. Y. Abdalla: Oxidation of thiols and modification of redox-sensitive signaling in human lung epithelial cells exposed to Pseudomonas pyocyanin. J Toxicol Environ Health A, 74(1), 43-51 (2010))
17. S. Pillai, M. Kovacs and S. Chellappan: Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation. Cancer Res, 70(12), 4931-40 (2010))
18. S. Braber, P. J. Koelink, P. A. Henricks, P. L. Jackson, F. P. Nijkamp, J. Garssen, A. D. Kraneveld, J. E. Blalock and G. Folkerts: Cigarette smoke-induced lung emphysema in mice is associated with prolyl endopeptidase, an enzyme involved in collagen breakdown. Am J Physiol Lung Cell Mol Physiol (2011))
19. H. Yao, J. W. Hwang, J. Moscat, M. T. Diaz-Meco, M. Leitges, N. Kishore, X. Li and I. Rahman: Protein kinase C zeta mediates cigarette smoke/aldehyde-and lipopolysaccharide-induced lung inflammation and histone modifications. J Biol Chem, 285(8), 5405-166
20. C. Lambert, J. McCue, M. Portas, Y. Ouyang, J. Li, T. G. Rosano, A. Lazis and B. M. Freed: Acrolein in cigarette smoke inhibits T-cell responses. J Allergy Clin Immunol, 116(4), 916-22 (2005)) (Pubitemid 41400561)
21. D. P. Ghilarducci and R. S. Tjeerdema: Fate and effects of acrolein. Rev Environ Contam Toxicol, 144, 95-146 (1995))
22. R. Talhout, A. Opperhuizen and J. G. van Amsterdam: Role of acetaldehyde in tobacco smoke addiction. Eur Neuropsychopharmacol, 17(10), 627-36 (2007)) (Pubitemid 47268752)
23. F. Facchinetti, F. Amadei, P. Geppetti, F. Tarantini, C. Di Serio, A. Dragotto, P. M. Gigli, S. Catinella, M. Civelli and R. Patacchini: Alpha,beta-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages. Am J Respir Cell Mol Biol, 37(5), 617-23 (2007)) (Pubitemid 350058193)
24. J. F. Stevens and C. S. Maier: Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res, 52(1), 7-25 (2008)) (Pubitemid 351211799)
25. S. Zhao, W. Xu, W. Jiang, W. Yu, Y. Lin, T. Zhang, J. Yao, L. Zhou, Y. Zeng, H. Li, Y. Li, J. Shi, W. An, S. M. Hancock, F. He, L. Qin, J. Chin, P. Yang, X. Chen, Q. Lei, Y. Xiong and K. L. Guan: Regulation of cellular metabolism by protein lysine acetylation. Science, 327(5968), 1000-44